1. Joseph Kost is an Israeli academic, currently holder of The Abraham and Bessie Zacks Chair in Biomedical Engineering and the past Dean of the Faculty of Engineering Sciences at the Ben-Gurion University of the Negev.
13 Facts About Joseph Kost
1. 2.
Joseph Kost obtained his MBA in 2004 at the Ben-Gurion University School of Business Administration.
3.
Joseph Kost completed three years of Post-Doctoral training at the University of Washington, Harvard Medical School and Massachusetts Institute of Technology.
4.
Joseph Kost has made significant contributions to the field of Biomedical Sciences.
5.
Joseph Kost has pioneered new medical technologies for disease management and was one of the pioneers developing artificial pancreas, studying polymeric system sensitive to glucose, and the entrapment of bone and Langerhans cells.
6.
Dr Joseph Kost was the first to propose the ultrasonically modulated systems in which the release of drugs, from polymers or through synthetic or biological membranes, can be repeatedly modulated at will from a position external to the delivery system.
7.
Joseph Kost contributions are particularly noteworthy in the field of transdermal drug delivery.
8.
Joseph Kost has come up with creative ways to open the skin for drug delivery without compromising safety.
9.
Since, Joseph Kost proposed a novel approach for a glucose flux continuous biosensor and noninvasive detection of amniotic fluid for prenatal testing.
10.
Additional applications studied by Joseph Kost are the use of ultrasound for on-demand targeted delivery of drugs from liposomes, combined ultrasonic and enzymatic debridement of necrotic eschars and the use of ultrasound for more efficient cancer gene therapy.
11.
The focus in these studies is on the effect of ultrasound on transport through tissues of no viral carriers developed by Joseph Kost complexed with miRNA.
12.
Joseph Kost was approved in the framework of the National 5-year Nano-Science and Technology Program.
13.
Joseph Kost has published four books, 37 book chapters, 113 papers, and more than 55 patents, principally in the area of Bio-Engineering Sciences.